MA53667A - Polythérapie associant un composé d'acylthiourée et de l'abiratérone - Google Patents
Polythérapie associant un composé d'acylthiourée et de l'abiratéroneInfo
- Publication number
- MA53667A MA53667A MA053667A MA53667A MA53667A MA 53667 A MA53667 A MA 53667A MA 053667 A MA053667 A MA 053667A MA 53667 A MA53667 A MA 53667A MA 53667 A MA53667 A MA 53667A
- Authority
- MA
- Morocco
- Prior art keywords
- polytherapy
- abiraterone
- combining
- acylthiourea compound
- acylthiourea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018174221 | 2018-09-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53667A true MA53667A (fr) | 2021-07-28 |
Family
ID=69887227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053667A MA53667A (fr) | 2018-09-18 | 2019-09-18 | Polythérapie associant un composé d'acylthiourée et de l'abiratérone |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210369739A1 (fr) |
| EP (1) | EP3854395A4 (fr) |
| JP (1) | JP7540946B2 (fr) |
| KR (1) | KR20210060465A (fr) |
| AU (1) | AU2019342447A1 (fr) |
| MA (1) | MA53667A (fr) |
| WO (1) | WO2020059744A1 (fr) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2287155B1 (fr) | 2008-04-10 | 2013-07-17 | Taiho Pharmaceutical Co., Ltd. | Composé acylthiourée ou son sel et leur utilisation |
| TWI594986B (zh) | 2011-12-28 | 2017-08-11 | Taiho Pharmaceutical Co Ltd | Antineoplastic agent effect enhancer |
| US20140011992A1 (en) * | 2012-12-20 | 2014-01-09 | Crystal Pharma, S.A.U. | Synthesis of abiraterone and related compounds |
| MX2015014046A (es) | 2013-04-04 | 2016-05-16 | Exelixis Inc | Combinaciones de farmacos para tratar cancer. |
| US9149471B2 (en) | 2013-09-30 | 2015-10-06 | National University Corporation Tokyo University Of Agriculture And Technology | Therapeutic agent for osteoporosis |
| DK3290405T3 (da) | 2015-04-30 | 2021-03-22 | Taiho Pharmaceutical Co Ltd | Mesylsyresalt af acylthioureaforbindelse, krystal deraf og fremgangsmåder til fremstilling deraf |
| ES2928684T3 (es) | 2015-06-25 | 2022-11-21 | Taiho Pharmaceutical Co Ltd | Agente terapéutico para la fibrosis |
| CA3053739C (fr) | 2017-02-15 | 2023-02-14 | Taiho Pharmaceutical Co., Ltd. | Composition pharmaceutique |
-
2019
- 2019-09-18 MA MA053667A patent/MA53667A/fr unknown
- 2019-09-18 WO PCT/JP2019/036530 patent/WO2020059744A1/fr unknown
- 2019-09-18 JP JP2020548546A patent/JP7540946B2/ja active Active
- 2019-09-18 AU AU2019342447A patent/AU2019342447A1/en active Pending
- 2019-09-18 KR KR1020217007611A patent/KR20210060465A/ko not_active Application Discontinuation
- 2019-09-18 EP EP19863028.7A patent/EP3854395A4/fr active Pending
- 2019-09-18 US US17/277,090 patent/US20210369739A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210060465A (ko) | 2021-05-26 |
| JPWO2020059744A1 (ja) | 2021-08-30 |
| US20210369739A1 (en) | 2021-12-02 |
| EP3854395A4 (fr) | 2022-06-15 |
| JP7540946B2 (ja) | 2024-08-27 |
| WO2020059744A1 (fr) | 2020-03-26 |
| EP3854395A1 (fr) | 2021-07-28 |
| AU2019342447A1 (en) | 2021-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3803274A4 (fr) | Planification de trajectoire | |
| IL283692A (en) | Novel composition | |
| EP3735685C0 (fr) | Panneau d'affichage | |
| EP3802254A4 (fr) | Planification de trajectoire | |
| DK3687994T3 (da) | Gadolinium-bærende pcta-baserede kontrastmidler | |
| MA52090A (fr) | Polythérapie | |
| EP3838900A4 (fr) | Composés de 3-aryloxy-3-aryl-propylamine et utilisations associées | |
| TWI799577B (zh) | 電鍍設備及電鍍方法 | |
| DK3808747T3 (da) | Imidazopyridinon-forbindelse | |
| EP3804549A4 (fr) | Vêtement de bain | |
| MA54243A (fr) | Composé de 1,3,4-oxadiazolone et médicament | |
| DK3556683T3 (da) | Fastgørelsesbånd | |
| EP3750883A4 (fr) | Composé aminoalkyle | |
| EP3679819A4 (fr) | Bande de protection de poignet | |
| EP3932909A4 (fr) | Composé de benzoindazolone et intermédiaire de celui-ci | |
| EP3864069C0 (fr) | Composé polycétone | |
| EP3767786A4 (fr) | Équipement de construction | |
| EP3870072A4 (fr) | Poinçon vasculaire | |
| EP3860328A4 (fr) | Dispositif d'alimentation en bande | |
| EP3806609A4 (fr) | Distributeur de bande | |
| EP3806608A4 (fr) | Dispositif d'alimentation de bande | |
| MA53667A (fr) | Polythérapie associant un composé d'acylthiourée et de l'abiratérone | |
| EP3780927A4 (fr) | Dispositif d'alimentation de bande | |
| EP4046230A4 (fr) | Ensemble électronique | |
| EP3892144A4 (fr) | Gant |